查看購物車
  • Simplified Chinese
  • English
  • Japanese
歐洲分子診斷市場預測至 2030 年 - 區域分析 - 按疾病領域、技術、產品和服務以及最終用戶
市場調查報告書
商品編碼
1452576

歐洲分子診斷市場預測至 2030 年 - 區域分析 - 按疾病領域、技術、產品和服務以及最終用戶

Europe Molecular Diagnostics Market Forecast to 2030 - Regional Analysis - by Disease Area, Technology, Product and Services, and End User
出版日期: | 出版商: The Insight Partners | 英文 134 Pages | 訂單完成後即時交付

價格

歐洲分子診斷市場預計將從2022年的45.9254億美元成長到2030年的112.2577億美元。預計2022年至2030年CAGR為11.8%。

相關疾病發生率激增推動歐洲分子診斷市場

分子診斷程序可用於檢測多種疾病，例如腫瘤疾病、傳染病、心臟病和免疫系統疾病；它們也可以用於基因測試，使用 DNA 和 RNA 等遺傳物質來診斷不同的疾病。癌症是全世界死亡的主要原因之一。及早發現這種疾病有助於防止患者死亡。根據 UK.GOV 2021 年 11 月 22 日發布的資料，COVID-19 的感染率為每 10 萬人約 422.7 人。因此，目標疾病盛行率的上升推動了分子診斷市場的成長。

歐洲分子診斷市場概況

歐洲分子診斷市場分為德國、英國、法國、義大利、西班牙和歐洲其他地區。該地區在全球分子診斷市場中佔有重要佔有率，預計 2022 年至 2030 年CAGR將強勁。歐洲市場的成長歸因於生命科學研究的不斷成長以及政府對傳染病檢測投資的增加。

慢性阻塞性肺病 (COPD)、糖尿病、癌症和關節炎等慢性疾病如果不及時治療可能會危及生命。例如，慢性淋巴球白血病（CLL）是德國最常見的白血病類型。根據德國《Arzteblatt》報道，德國 CLL 的盛行率約為每 10 萬人中 6 例；每年有近 850 名女性和 1,000 名男性死於 CLL。

歐洲分子診斷市場收入及 2030 年預測（百萬美元）

歐洲分子診斷市場細分

歐洲分子診斷市場分為疾病領域、技術、產品和服務、最終用戶和國家。

根據疾病領域，歐洲分子診斷市場分為傳染病、腫瘤、基因檢測、心臟病、免疫系統疾病等。到 2022 年，傳染病領域將佔據歐洲最大的分子診斷市場。

根據技術，歐洲分子診斷市場分為聚合酶鍊式反應（PCR）、原位雜合技術、等溫核酸擴增技術（INAAT）、DNA定序和下一代定序（NGS）、DNA微陣列等。聚合酶鏈反應 (PCR) 領域在 2022 年佔據歐洲最大的分子診斷市場佔有率。聚合酶鏈反應 (PCR) 進一步細分為 RT-PCR、qPCR、多重 PCR 等。

根據產品和服務，歐洲分子診斷市場分為檢測和試劑盒、儀器、服務和軟體。到 2022 年，檢測和試劑盒領域將佔據歐洲最大的分子診斷市場。

根據最終用戶，歐洲分子診斷市場分為診斷實驗室、醫院和診所、研究和學術機構等。到 2022 年，診斷實驗室領域將佔據歐洲最大的分子診斷市場。

根據國家/地區，歐洲分子診斷市場分為德國、英國、法國、義大利、西班牙和歐洲其他地區。 2022年，德國在歐洲分子診斷市場佔據主導地位。

Abbott Laboratories、Agilent Technologies Inc、Thermo Fisher Scientific Inc、F. Hoffmann-La Roche Ltd、Qiagen NV、bioMerieux SA、Illumina Inc、Danaher、Siemens Healthineers AG 和 Novartis AG 是歐洲分子診斷領域的一些領先公司市場。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：歐洲分子診斷市場格局

  • 概述
  • PEST分析
    • 歐洲PEST分析

第 5 章：歐洲分子診斷市場 - 主要產業動態

  • 主要市場促進因素：
    • 新產品的開發和即時檢測需求的增加
    • 相關疾病的盛行率激增
  • 市場限制
    • 與分子測試相關的局限性
  • 市場機會
    • 分子診斷技術的進步
  • 未來的趨勢
    • 個性化醫療中的分子診斷
  • 影響分析：

第 6 章：分子診斷市場 - 歐洲市場分析

  • 歐洲分子診斷市場收入，2022 - 2030

第 7 章：歐洲分子診斷市場 - 2030 年收入與預測 - 按疾病領域

  • 概述
  • 2022 年及 2030 年歐洲分子診斷市場收入佔有率，依疾病領域分類（%）
  • 腫瘤學
  • 傳染病
  • 基因檢測
  • 心臟病
  • 免疫系統疾病
  • 其他

第 8 章：歐洲分子診斷市場 - 收入和 2030 年預測 - 按技術分類

  • 概述
  • 2022 年和 2030 年歐洲分子診斷市場收入佔有率（按技術分類）（%）
  • 聚合酶鍊式反應
  • 等溫核酸擴增技術（INAAT）
  • DNA 定序和二代定序 (NGS)
  • DNA微陣列
  • 原位雜合技術 (ISH)
  • 其他

第 9 章：歐洲分子診斷市場 - 收入和 2030 年預測 - 按產品和服務

  • 概述
  • 2022 年和 2030 年歐洲分子診斷市場收入佔有率（按產品和服務分類）（%）
  • 檢測方法和試劑盒
  • 儀器
  • 服務和軟體

第 10 章：歐洲分子診斷市場 - 收入和 2030 年預測 - 按最終用戶

  • 概述
  • 2022 年和 2030 年歐洲分子診斷市場收入佔有率（按最終用戶分類）（%）
  • 醫院和診所
  • 診斷實驗室
  • 研究和學術機構
  • 其他

第 11 章：歐洲分子診斷市場 - 國家分析

  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 歐洲其他地區

第12章：歐洲分子診斷市場產業格局

  • 概述
  • 市場上公司採取的成長策略（%）
  • 有機發展
    • 概述
  • 無機發展
    • 概述

第 13 章：歐洲分子診斷市場，主要公司概況

  • Abbott Laboratories
  • Agilent Technologies Inc
  • Thermo Fisher Scientific Inc
  • F. Hoffmann-La Roche Ltd
  • Qiagen NV
  • bioMerieux SA
  • Illumina Inc
  • Danaher
  • Siemens Healthineers AG
  • Novartis AG

第 14 章：附錄

Product Code: TIPRE00026715

The Europe molecular diagnostics market is expected to grow from US$ 4,592.54 million in 2022 to US$ 11,225.77 million by 2030. It is estimated to grow at a CAGR of 11.8% from 2022 to 2030.

Surging Prevalence of Associated Diseases Fuels Europe Molecular Diagnostics Market

Molecular diagnostics procedures can be employed in the detection of a wide range of conditions such as oncologic diseases, infectious diseases, cardiac diseases, and immune system disorders; they can also be used in genetic testing using genetic material such as DNA and RNA for the diagnosis of different diseases. Cancer is one of the leading causes of death worldwide. The early detection of the disease can help prevent death among the patients. According to the data published by the UK.GOV on November 22, 2021, the infection rate of COVID-19 was ~422.7 per 100,000 population. Thus, the rising prevalence of target diseases fuels the molecular diagnostics market growth.

Europe Molecular Diagnostics Market Overview

The European molecular diagnostics market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant share of the global molecular diagnostics market and is expected to register a robust CAGR during 2022-2030. The market growth in Europe is attributed to growing life science research and an increase in government investment in testing infectious diseases.

Chronic diseases such as chronic obstructive pulmonary disease (COPD), diabetes, cancer, and arthritis can be life-threatening if left untreated. For instance, chronic lymphocytic leukemia (CLL) is the most common type of leukemia in Germany. According to the Deutsches Arzteblatt, the prevalence of CLL in Germany stands at ~6 cases per 100,000; nearly 850 women and 1,000 men die from CLL every year.

Europe Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

Europe Molecular Diagnostics Market Segmentation

The Europe molecular diagnostics market is segmented into disease area, technology, product and services, end user, and country.

Based on disease area, the Europe molecular diagnostics market is segmented into infectious disease, oncology, genetic testing, cardiac diseases, immune system disorders, and others. The infectious disease segment registered the largest Europe molecular diagnostics market share in 2022.

Based on technology, the Europe molecular diagnostics market is segmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), DNA sequencing and next-generation sequencing (NGS), DNA microarrays, and others. The polymerase chain reaction (PCR) segment registered the largest Europe molecular diagnostics market share in 2022. The polymerase chain reaction (PCR) is further sub segmented into RT-PCR, qPCR, multiplex PCR, and others.

Based on product and services, the Europe molecular diagnostics market is segmented into assays and kits, instruments, and services and software. The assays and kits segment registered the largest Europe molecular diagnostics market share in 2022.

Based on end users, the Europe molecular diagnostics market is segmented into diagnostic laboratories, hospitals and clinics, research and academic institutes, and others. The diagnostic laboratories segment held the largest Europe molecular diagnostics market share in 2022.

Based on country, the Europe molecular diagnostics market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe molecular diagnostics market in 2022.

Abbott Laboratories, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, bioMerieux SA, Illumina Inc, Danaher, Siemens Healthineers AG, and Novartis AG are some of the leading companies operating in the Europe molecular diagnostics market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Molecular Diagnostics Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Europe PEST Analysis

5. Europe Molecular Diagnostics Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Development of New Products and Increase in Demand for Point-of-Care Testing
    • 5.1.2 Surging Prevalence of Associated Diseases
  • 5.2 Market Restraints
    • 5.2.1 Limitations Associated with Molecular Testing
  • 5.3 Market Opportunities
    • 5.3.1 Advancements in Molecular Diagnostics Technologies
  • 5.4 Future Trends
    • 5.4.1 Molecular Diagnostics in Personalized Medicine
  • 5.5 Impact Analysis:

6. Molecular Diagnostics Market - Europe Market Analysis

  • 6.1 Europe Molecular Diagnostics Market Revenue (US$ Mn), 2022 - 2030

7. Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Disease Area

  • 7.1 Overview
  • 7.2 Europe Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
  • 7.3 Oncology
    • 7.3.1 Overview
    • 7.3.2 Oncology: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Infectious Disease
    • 7.4.1 Overview
    • 7.4.2 Infectious Disease: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Genetic Testing
    • 7.5.1 Overview
    • 7.5.2 Genetic Testing: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Cardiac Diseases
    • 7.6.1 Overview
    • 7.6.2 Cardiac Diseases: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Immune System Disorders
    • 7.7.1 Overview
    • 7.7.2 Immune System Disorders: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Technology

  • 8.1 Overview
  • 8.2 Europe Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
  • 8.3 Polymerase Chain Reaction
    • 8.3.1 Overview
    • 8.3.2 PCR: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.1 RT-PCR
        • 8.3.2.1.1 Overview
    • 8.3.3 RT-PCR: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.3.1 qPCR
        • 8.3.3.1.1 Overview
    • 8.3.4 qPCR: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.4.1 Multiplex PCR
        • 8.3.4.1.1 Overview
    • 8.3.5 Multiplex PCR: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.5.1 Others
        • 8.3.5.1.1 Overview
    • 8.3.6 Others: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 8.4.1 Overview
    • 8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT): Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 DNA Sequencing and Next-Generation Sequencing (NGS)
    • 8.5.1 Overview
    • 8.5.2 DNA Sequencing and Next-Generation Sequencing (NGS): Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 DNA Microarrays
    • 8.6.1 Overview
    • 8.6.2 DNA Microarrays: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 In-Situ Hybridization (ISH)
    • 8.7.1 Overview
    • 8.7.2 In-Situ Hybridization (ISH): Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

  • 9.1 Overview
  • 9.2 Europe Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
  • 9.3 Assays and Kits
    • 9.3.1 Overview
    • 9.3.2 Assays and Kits: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Instruments
    • 9.4.1 Overview
    • 9.4.2 Instruments: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Services and Software
    • 9.5.1 Overview
    • 9.5.2 Services and Software: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 - by End User

  • 10.1 Overview
  • 10.2 Europe Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
  • 10.3 Hospitals and Clinics
    • 10.3.1 Overview
    • 10.3.2 Hospitals and Clinics: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Diagnostics Laboratories
    • 10.4.1 Overview
    • 10.4.2 Diagnostics Laboratories: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Research and Academic Institutes
    • 10.5.1 Overview
    • 10.5.2 Research and Academic Institutes: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.6 Others
    • 10.6.1 Overview
    • 10.6.2 Others: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Molecular Diagnostics Market - Country Analysis

  • 11.1 Europe Molecular Diagnostics Market, Revenue and Forecast to 2030
    • 11.1.1 Overview
      • 11.1.1.1 Europe Molecular Diagnostics Market by Country
    • 11.1.2 Germany
      • 11.1.2.1 Overview
    • 11.1.3 Germany: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.4 Germany: Molecular Diagnostics Market, by Disease Area
    • 11.1.5 Germany: Molecular Diagnostics Market, by Technology
      • 11.1.5.1 Germany: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.6 Germany: Molecular Diagnostics Market, by Product and Services
    • 11.1.7 Germany: Molecular Diagnostics Market, by End User
    • 11.1.8 UK
      • 11.1.8.1 Overview
    • 11.1.9 UK : Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.10 UK: Molecular Diagnostics Market, by Disease Area
    • 11.1.11 UK: Molecular Diagnostics Market, by Technology
      • 11.1.11.1 UK: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.12 UK: Molecular Diagnostics Market, by Product and Services
    • 11.1.13 UK: Molecular Diagnostics Market, by End User
    • 11.1.14 France
      • 11.1.14.1 Overview
    • 11.1.15 France: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.16 France: Molecular Diagnostics Market, by Disease Area
    • 11.1.17 France: Molecular Diagnostics Market, by Technology
      • 11.1.17.1 France: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.18 France: Molecular Diagnostics Market, by Product and Services
    • 11.1.19 France: Molecular Diagnostics Market, by End User
    • 11.1.20 Italy
      • 11.1.20.1 Overview
    • 11.1.21 Italy: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.22 Italy: Molecular Diagnostics Market, by Disease Area
    • 11.1.23 Italy: Molecular Diagnostics Market, by Technology
      • 11.1.23.1 Italy: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.24 Italy: Molecular Diagnostics Market, by Product and Services
    • 11.1.25 Italy: Molecular Diagnostics Market, by End User
    • 11.1.26 Spain
      • 11.1.26.1 Overview
    • 11.1.27 Spain: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.28 Spain: Molecular Diagnostics Market, by Disease Area
    • 11.1.29 Spain: Molecular Diagnostics Market, by Technology
      • 11.1.29.1 Spain: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
        • 11.1.29.1.1 Spain: Molecular Diagnostics Market, by Product and Services
    • 11.1.30 Spain: Molecular Diagnostics Market, by End User
    • 11.1.31 Rest of Europe
      • 11.1.31.1 Overview
    • 11.1.32 Rest of Europe: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.33 Rest of Europe: Molecular Diagnostics Market, by Disease Area
    • 11.1.34 Rest of Europe: Molecular Diagnostics Market, by Technology
      • 11.1.34.1 Rest of Europe: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.35 Rest of Europe: Molecular Diagnostics Market, by Product and Services
    • 11.1.36 Rest of Europe: Molecular Diagnostics Market, by End User

12. Europe Molecular Diagnostics Market Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in the Market (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Europe Molecular Diagnostics Market, Key Company Profiles

  • 13.1 Abbott Laboratories
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Agilent Technologies Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Thermo Fisher Scientific Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 F. Hoffmann-La Roche Ltd
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Qiagen NV
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 bioMerieux SA
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Illumina Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Danaher
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Siemens Healthineers AG
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Novartis AG
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Molecular Diagnostics Market Segmentation
  • Table 2. Germany: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Disease Area
  • Table 3. Germany: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 4. Germany: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 5. Germany: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 6. Germany: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 7. UK: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 8. UK: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 9. UK: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 10. UK: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 11. UK: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 12. France: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 13. France: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 14. France: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 15. France: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 16. France: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 17. Italy: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 18. Italy: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 19. Italy: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 20. Italy: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 21. Italy: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 22. Spain: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 23. Spain: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 24. Spain: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 25. Spain: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 26. Spain: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 27. Rest of Europe: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 28. Rest of Europe: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 29. Rest of Europe: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 30. Rest of Europe: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 31. Rest of Europe: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 32. Organic Developments Done By Companies
  • Table 33. Inorganic Developments Done By Companies
  • Table 34. Glossary of Terms, Molecular Diagnostics Market

List Of Figures

  • Figure 1. Europe - PEST Analysis
  • Figure 2. Europe Molecular Diagnostics Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Molecular Diagnostics Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. Europe Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
  • Figure 6. Oncology: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Infectious Disease: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Genetic Testing: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Cardiac Diseases: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Immune System Disorders: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Others: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Europe Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 13. PCR: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. RT-PCR: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. qPCR: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Multiplex PCR: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Others: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Isothermal Nucleic Acid Amplification Technology (INAAT): Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. DNA Sequencing and Next-Generation Sequencing (NGS): Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. DNA microarrays: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. In-Situ Hybridization (ISH): Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Others: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Europe Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
  • Figure 24. Assays and Kits: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Instruments: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Services and Software: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Europe Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 28. Hospitals and Clinics: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Ambulatory Surgical Centers: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Research and Academic Institutes: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Others: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Europe Molecular Diagnostics Market, By country, 2022 ($Mn)
  • Figure 33. Europe Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)
  • Figure 34. Germany: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 35. UK: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 36. France: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 37. Italy: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 38. Spain: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 39. Rest of Europe: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 40. Growth Strategies Done by the Companies in the Market (%)